Brief: Cardiff Oncology Reports Qtrly Loss Per Share $0.17
05/08/2021 23:22
Aug 5 (Reuters) - Cardiff Oncology Inc CRDF.O :
* CARDIFF ONCOLOGY REPORTS SECOND QUARTER 2021 RESULTS AND
PROVIDES BUSINESS UPDATES
* CARDIFF ONCOLOGY INC- QTRLY LOSS PER SHARE $0.17
Source text for Eikon: ID:nPn8RL0bba
Further company coverage: CRDF.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cardiff Oncology
See all newsBrief: Cardiff Oncology Receives FDA Orphan Drug Designation For Onvansertib In Chronic Myelomonocytic Leukemia
Corrected: Cardiff Oncology Q2 operating expenses fall on lower R&D costs
Cardiff Oncology Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Cardiff Oncology sinks on direct equity offering